Analyzing Larger Oligonucleotides

In recent years, mRNA-based and larger oligo therapeutics have gained attention, placing a spotlight on the need for high-purity, well-characterized oligonucleotides. Professor Dickman has been at the forefront of this effort, focusing on the purification and analysis of these large, complex molecules. In this video, we explore the unique challenges his team is encountering in handling mRNAs. From stability issues to analytical limitations, Professor Dickman shares key insights into this evolving field. Watch the discussion above.